Polytherics Lands $20.8M to Fund Antitope Acquisition
By Nuala Moran
Wednesday, July 31, 2013
LONDON Polytherics Ltd. raised £13.5 million (US$20.8 million) in a private round to fund the acquisition of antibody engineering specialist Antitope Ltd. and provide working capital to build on the enlarged company's portfolio of antibody development technologies.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.